Global Non-Life Insurance Industry Market 2017 -Develop Market-Entry and Market Expansion Strategies

Global Non-Life Insurance Industry

PUNE, MAHARASHTRA, INDIA, January 15, 2018 /EINPresswire.com/ —

WiseGuyReports published new report, titled “Non-Life Insurance Global Industry Almanac”

SUMMARY

Global Non-Life Insurance industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/2775515-non-life-insurance-global-industry-almanac-2017

Synopsis

Essential resource for top-line data and analysis covering the global non-life insurance market. Includes market size and segmentation data, textual and graphical analysis of market growth trends and leading companies.

Key highlights

– The non-life insurance market consists of the general insurance market segmented into motor, property, liability and other insurance.
– The other segment is made up of non-life insurance products including health, travel, and accident cover among others.
– The value of the non-life insurance market is shown in terms of gross premium incomes. Gross premium income is defined as the insurer’s premium income for the year from its policies, calculated without reduction for reinsurance premiums paid or payable by the insurer.
– Any currency conversions used in the report have been calculated using constant 2016 annual average exchange rates.
– The global non-life insurance market had total gross written premiums of $2,046.3bn in 2016, representing a compound annual growth rate (CAGR) of 4.7% between 2012 and 2016.
– The motor segment was the market's most lucrative in 2016, with total gross written premiums of $790.4bn, equivalent to 38.6% of the market's overall value.
– The rapid emergence of the Asia-Pacific market, and particularly of the Chinese market, has largely contributed to the growth of the global market in recent years. This contribution becomes more apparent from the fact that developed markets such as the European and the US have grown below the global average amid saturation since demand is constrained by high penetration of non-life insurance.

Scope

– Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the global non-life insurance market
– Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the global non-life insurance market
– Leading company profiles reveal details of key non-life insurance market players’ global operations and financial performance
– Add weight to presentations and pitches by understanding the future growth prospects of the global non-life insurance market with five year forecasts

Key points

– What was the size of the global non-life insurance market by value in 2016?
– What will be the size of the global non-life insurance market in 2021?
– What factors are affecting the strength of competition in the global non-life insurance market?
– How has the market performed over the last five years?
– Who are the top competitors in the global non-life insurance market?

Table of Contents

EXECUTIVE SUMMARY
Market value
Market value forecast
Category segmentation
Geography segmentation
Market share
Introduction
What is this report about?
Who is the target reader?
How to use this report

..CONTINUED

About Us

Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.

For accessing accurate and deep understanding and to gain latest insights and key developments in the area of your interest, we also have a list of conferences in which you will be interested in, for more information, cordially check

https://www.wiseguyreports.com/conferences

For updating knowledge or for thoroughly understanding various terminologies, we also have vast list of seminars for your reference, for more information cordially check

https://www.wiseguyreports.com/seminars

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Banknotes Design and Currency Printing – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018 – 2023

Banknotes Design and Currency Printing Market 2017 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2022

PUNE, MAHARASHTRA, INDIA, January 15, 2018 /EINPresswire.com/ — Summary

WiseGuyReports.com adds “Banknotes Design and Currency Printing Market 2017 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2022” reports to its database.

This report provides in depth study of “Banknotes Design and Currency Printing Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Banknotes Design and Currency Printing Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

This report studies the global Banknotes Design and Currency Printing market, analyzes and researches the Banknotes Design and Currency Printing development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
Federal Reserve
Bank of Japan
European Central Bank
Banco de Mexico
Reserve Bank of Australia
People's Bank of China
Bank of Canada
Central Bank of Russia
Banco Central do Brasil
Reserve Bank of India

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/2688248-global-banknotes-design-and-currency-printing-market-size-status-and-forecast-2022

Market segment by Regions/Countries, this report covers
United States
EU
Japan
China
India
Southeast Asia

Market segment by Type, the product can be split into
Banknotes Design
Currency Printing

Market segment by Application, Banknotes Design and Currency Printing can be split into
Offset lithography
Intaglio
letterpress

At any Query @ https://www.wiseguyreports.com/enquiry/2688248-global-banknotes-design-and-currency-printing-market-size-status-and-forecast-2022

Table of Contents

Global Banknotes Design and Currency Printing Market Size, Status and Forecast 2022
1 Industry Overview of Banknotes Design and Currency Printing
1.1 Banknotes Design and Currency Printing Market Overview
1.1.1 Banknotes Design and Currency Printing Product Scope
1.1.2 Market Status and Outlook
1.2 Global Banknotes Design and Currency Printing Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Banknotes Design and Currency Printing Market by Type
1.3.1 Banknotes Design
1.3.2 Currency Printing
1.4 Banknotes Design and Currency Printing Market by End Users/Application
1.4.1 Offset lithography
1.4.2 Intaglio
1.4.3 letterpress

2 Global Banknotes Design and Currency Printing Competition Analysis by Players
2.1 Banknotes Design and Currency Printing Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
3.1 Federal Reserve
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Banknotes Design and Currency Printing Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 Bank of Japan
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Banknotes Design and Currency Printing Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 European Central Bank
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Banknotes Design and Currency Printing Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 Banco de Mexico
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Banknotes Design and Currency Printing Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 Reserve Bank of Australia
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Banknotes Design and Currency Printing Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 People's Bank of China
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Banknotes Design and Currency Printing Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 Bank of Canada
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Banknotes Design and Currency Printing Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 Central Bank of Russia
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Banknotes Design and Currency Printing Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 Banco Central do Brasil
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Banknotes Design and Currency Printing Revenue (Value) (2012-2017)
3.9.5 Recent Developments
3.10 Reserve Bank of India
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Banknotes Design and Currency Printing Revenue (Value) (2012-2017)
3.10.5 Recent Developments

4 Global Banknotes Design and Currency Printing Market Size by Type and Application (2012-2017)
4.1 Global Banknotes Design and Currency Printing Market Size by Type (2012-2017)
4.2 Global Banknotes Design and Currency Printing Market Size by Application (2012-2017)
4.3 Potential Application of Banknotes Design and Currency Printing in Future
4.4 Top Consumer/End Users of Banknotes Design and Currency Printing

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=2688248

Continued….

Contact Us: sales@wiseguyreports.com

Ph: +1-646-845-9349 (US) ; Ph: +44 208 133 9349 (UK)

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

LiveEdu Project Screen – Coming to a City Near You

LiveEdu Project Screen

Watch projects live in your city on LiveEdu Project Screens for your professional development.

SAN FRANCISCO, CALIFORNIA, UNITED STATES, January 12, 2018 /EINPresswire.com/ — The wait is not long now. LiveEdu Project Screens are coming soon to your city. LiveEdu is a decentralized professional development platform that teaches people how to build complete products in future technological fields. They are the YouTube for online education and professional development and with this new and innovative venture you will be able to improve your professional skills just by watching their project screens across the globe. For the audio of these live project screens, you simply download the iOS or Android version of the LiveEdu app and use your purchased Education coins to listen in. VIOLA! You are on your way to learning how to excel in your chosen field.

The platform will have eight main topics and several subcategories; with the main topics being: Artificial Intelligence, Cybersecurity, Game Development, Data Science, Cryptocurrencies, Programming, Design, Augmented and Virtual Reality. From these topics and subcategories, project creators will build over ten thousand (10,000) projects. Not only that, they will be in several different languages, including English, Chinese, and Russian.

With the first LiveEdu Project Screen slated to be erected in San Francisco, it is important to start buying those Education coins (EDU coins). Since it is EDU coin holders who will have voting powers to decide which city the next project screen will be launched, by using their coins to vote. Conversely, if you purchase a substantial amount of EDU coins, you can vote and push your city to the top.

Presently, the plan is to launch project screens in
*Beijing
*New York
*London
*Shanghai
*Seoul
*Tokyo
*Amsterdam
*Berlin, etc.

The LiveEdu platform is a great ecosystem for people to improve their existing skill and we are opening up the world of product development with blockchain technology.

Website and Social Media
Website: https://tokensale.liveedu.tv/
How to Buy EDU tokens: https://tokensale.liveedu.tv/en/buy-tokens/how-to-buy-edu-tokens
Whitepaper: https://tokensale.liveedu.tv/static/docs/LiveEdu-white-paper.pdf
Telegram: https://t.me/liveeduico

n/a
LiveEdu
n/a
email us here


Source: EIN Presswire

Costa Rica Doesn't Deny Trying to Assassinate US Investor at CAFTA Hearing at World Bank in Washington. DC

CAFTA Heraing Room, World Bank, Washington, DC

Mark Baker Questions Nestor Morea

Mark Baker Questions Nestor Morea

uis Martinez Zuniga, Cost Rica Criminal Prosecutor

Luis Martinez Zuniga, Cost Rica Criminal Prosecutor

”The Prosecution didn't go that well for the Cost Rican State, maybe the Best Way is to "KILL HIM". "Nestor Morea" Costa Rica Criminal Attorney for David Aven.

The Prosecution didn't go that well for the Costa Rican State, Maybe the Best Way is to Kill Him.”

— Nestor Morea Criminal Attorney for David Aven

LOS ANGELES, CA, US, January 12, 2018 /EINPresswire.com/ — One of the most remarkable statements made at the CAFTA hearing, was made by Nestor Morea, David Aven’s criminal attorney. See above statement below in video at the 8-minute mark. The “him” Mr. Morea is refering to in “KILL HIM” is David Aven.

In all trials, there’s a provision for attorneys to object to any false statements being made under oath. If there’s no objection, the statement stands as being true. Costa Rica’s attorney Christian Leathley, didn’t object to Mr. Morea’s , “KILL HIM”, statement. He could have said, objection there's no evidence that Costa Rica had anything to do with the attempt to kill Mr. Aven. Or after Mr. Morea finished being questioned, Mr. Leathley, could have asked Mr. Morea, if he had any evidence to prove Costa Rica had anything to do with the attempted assassination of Mr. Aven? However, neither of the above happened, therefore Mr. Morea’s statement stands as being truthful.

In watching all the hearing videos, there weren’t any objections to any statements made by David Aven, during his lengthy testimony at the CAFTA hearing. Therefore, his statements stand as being truthful. This is a very important element in any legal proceedings. If an attorney doesn’t make an objection, statements made stand as being truthful.

As well as watching all the hearing videos, I also watched all the criminal trial videos, in which Mr. Nestor Morea was defense attorney for David Aven and Jovan Damjanac. I would say Mr. Morea was being kind when he said the “prosecution didn’t go well.” After watching the trial videos, this reporter thought the trial was a total prosecutorial disaster. Mr. Martinez’s own witnesses disagreed with him, none of his witnesses provided any evidence that either Mr. Aven or Mr. Damjanac committed a crime or had an intent to commit a crime.

In Costa Rica, a defendant has a right to make a declaration at the end of the trial, just before closing arguments. Mr. Aven spoke for about one-hour-30-minutes, and ripped Mr. Martinez for not considering objective evidence. Mr. Aven stated that Martinez provided no evidence to prove his case. He showed the Judge Government reports and permits, all saying there was no wetlands. Mr. Aven pointed out Dr. Curbero, the director of INTA, testified there was no wetlands. That’s the report that Mr. Martinez told Mr. Aven, “HE DIDN'T BELIEVE”. Just looking at the video objectively, shows that Mr. Martinez was either corrupt, incompetent or both. Mr. Martinez had every right to stand up, at any time, and object to “ANYTHING” Mr. Aven said. However, he was either too shocked or incompetent to raise one objection. Therefore, all statements made were as accepted as truthful.

After Mr. Aven made his statement, instead of Mr. Martinez standing up and giving his closing statement, he asked the judge for a continuance, even though it was only 11am. Over Mr. Aven’s objection, the Judge granted the continuance.

One day before the next hearing the Judge called in sick. Costa Rica had no alternative judge, as required by law, so the hearing didn’t take place. In Costa Rica, if a trial goes more than 10-days between hearing dates, it’s a mistrial. On the 11th day, Mr. Martinez filed for a mistrial and new trial. Mr. Aven's attorney objected saying it wasn’t defendant’s fault there was no alternative Judge. Martinez wouldn’t agree to have the trial continue after the Judge came back to work. Mr. Morea filed two appeals, both to no avail. Mr. Aven and Mr. Damjanac were forced to go through the expense and ordeal of an entire new trial. Does any of this sound fair or reasonable?

This was the most egregious, abusive and corrupt ruling this reporter ever witnesses. It perfectly described what Mr. Fernando Zumbado said in his witness statement about Costa Rica’s criminal justice system,

“As a result of my own experience, my impression of the criminal justice system is one of subjectivity and mediocrity. It is a system in which I no longer have any confidence.”

This is exactly the same experience Mr. Aven and Mr. Damjanac had as well and they feel exactly the same.

About two months later, Mr. Aven and another US Investor,Jeff Shioleno, were driving back from the project site, a motorcycle with two riders passed them on the highway, firing six gun shots into their car narrowly missing them. Emails sent to Mr. Aven after the shooting connected the shooting to problems he was having with the Government, telling Mr. Aven to “leave the country, or be killed.” Mr. Aven, not wanting to get killed, left the country and moved back to US.

Mr. Morea testified at the hearing that he attempted to get Costa Rica to provide Mr. Aven’s security for the second trial, they refused. Mr. Aven testified he tried to get the US Embassy to provide him security, they also refused. When the second trial was scheduled in January of 2014, Mr. Aven was in a hospital having surgery and couldn’t return for second trial. Although, Mr. Aven sent letters from his doctor to the court, the Judge disregarded Mr. Aven medical condition and put an arrest warrant out for him, for failing to show up for the second trial.

Mr. Martinez, testified at the CAFTA hearing that he was the one that requested the INTERPOL red notice to be placed on Mr. Aven. Initially, INTERPOL did issue the red notice on Mr. Aven, but later took it down after Mr. Aven’s attorney objected stating, it did not meet INTERPOL red notice guidelines. All of the above, plus the destruction of a multi-million-dollar project was caused by one Rogue prosecutor, Mr. Luis Martinez, who refused to follow Costa Rica law. Does any of this sound PURA VIDA to you! We Report, You Decide!

Click to see testimony video from the CAFTA hearing at the World Bank. See CAFTA submission filings on ITA Website. Watch for more corruption reports and visit our website at CRBUZZ.com.

Nick Johnson
The Corruption Report
323-610-1362
email us here

Nestor Morea Testimony at CAFTA Hearing Talks About Assassination Attempt


Source: EIN Presswire

BND Levante Group S.A. has been Awarded by The European Global Banking & Finance Awards 2018

BND award logo

BND Levante Group S.A. announced today that it has been awarded for Best Alternative Investment in Spain by The European Global Banking & Finance Awards 2018.

BENIDORM, SPAIN, January 12, 2018 /EINPresswire.com/ — BND Levante Group announced today that it has been awarded for Best Alternative Investment in Spain by The European Global Banking & Finance Awards 2018.

BND Levante Group thanks all fans and voters for their vote: http://www.the-european.eu/story-12648/bnd-levante-group.html.

The European, over the last several years, has been celebrating achievement, innovation and excellence through its annual awards programme. The aim is to give corporate organisations an insight into various achievements within a range of organisations.

About BND Levante Group

BND Levante Group was incorporated as an independent Spanish company to issue corporate bonds as alternative financing to buy prime real estate in order to meet the growing demand for short-term holiday rentals in Benidorm.

BND Levante Group owns and generates income from real-estate properties in Benidorm. It allows anyone to invest in real estate in a simple, easy and safe way: through the purchase of bonds online.

Benidorm is the Las Vegas of Spain. Throughout the year, this city is occupied by 85% of tourists from all around the world. Benidorm is an ideal place for short-term rentals. Short-term rentals are the most profitable in terms of investment.

The value of the bond is secured by BND Levante Group prime real estate portfolio. All bond holders have the first right on the prime real estate BND Levante Group buys in Benidorm. All the properties BND buys have a long-time history of rental income that will cover the interest rate on the bond.

Paul Dunn
BND Levante Group SA
+34 965 798 373
email us here


Source: EIN Presswire

TITAN confirms December 2017 that they will execute New Gas Terminal in Curaçao according to the BID they won

WILLEMSTAD, DUTCH CARIBBEAN, CURACAO, January 12, 2018 /EINPresswire.com/ — Titan confirms in December 2017 to Curaçao Government Company (RDK) and MDP team that they will carry on the project of the Gas Terminal in Bullenbay under the conditions and terms as specified in the RFP.

http://curacaotimes.com/en/titan-confirms-december-2017-that-they-will-execute-new-gas-terminal-in-curacao-according-to-the-bid-they-won/

Curaçao Times
CuracaoTimes.com
+59995241625
email us here


Source: EIN Presswire

Terra Tech Corp. (OTCQX: TRTC) Be Afraid – Massive Stock Dilution Eroding Shareholder Value

http://www.EmergingGrowth.com

Emerging Growth Companies

The massive stock dilution that has taken place over the past years greatly limits the chance that this stock will deliver any long-term growth for investors.

Terra Tech Corp. (OTCQX:TRTC)

MIAMI, FLORIDA, USA, January 12, 2018 /EINPresswire.com/ — Over the past few weeks, Terra Tech Corp (OTCQX: TRTC) has been one of the most highly followed cannabis stocks in the U.S. This follows its +17% rally to a high of $0.45 a share on January 2nd. The rally, which was captured on financial media outlets such as Seeking Alpha, was prompted by an announcement that TRTC had received temporary authorization from the State of California to distribute recreational marijuana.

This news coincided with California’s landmark move to legalize recreational marijuana at the beginning of 2018, giving the stock additional impetus. Many businesses are angling for a piece of the California pie, which is considered to be the largest marijuana market in the U.S.

Competitively positioned

As of January 9th 2018, there were 134 businesses licensed for “recreational sales” in California. However, TRTC is competitively positioned due to the fact that it will distribute recreational marijuana through its Blüm retail dispensaries in Oakland and Santa Ana, both of which already have a strong footing in the market due to their relative success in medical marijuana.

In addition to the good prospects in California, TRTC also has a lot of positive indicators from an operational perspective. It is has an expansive brick-and-mortar footprint, with one dispensary in Reno (Nevada) and three in Las Vegas (Nevada). It is currently constructing a Blüm dispensary in San Leandro (California), which is expected to open to the public in early 2018.

The retail segment of TRTC’s business is currently focused on medical marijuana, with the exception of California. But with legalization of recreational marijuana expected to accelerate across many states, despite Attorney General Jeff Session’s stiff opposition, TRTC will be able to increase revenue per store by adding recreational marijuana to its shelves—just as it has already done in California.

TRTC is also involved in the agricultural side of cannabis, a move that exposes it to every stage of the marijuana value chain from seed to sale. This, coupled with the fact that it was one of the first publicly traded companies in the space, have competitively positioned the stock, paving the way for in-depth coverage on tier-1 financial outlets such as Bloomberg and The Wall Street Journal.

TRTC can actually tout terms such as “early mover” or “integrated player” in its external communication without being guilty of riding on buzzwords in order to capture investor and stakeholder attention. Moreover, TRTC’s SEC filings, which are all available on its website, show that revenues have increased from just over half a million in 2012 to $25 million in 2016.

Despite this seemingly strong bull case, TRTC’s share price paints a different picture. There has been no sustained share price improvement, nor has the stock moved into new price territories since listing. Its five year price chart, shown below, puts this into clearer perspective.

Since 2014 TRTC share price has remained invariably suppressed
Why is TRTC not recording any significant capital gains for investors, despite being one of the most hotly followed cannabis stocks churning out high revenues year after year?

Convertible note junkie

The reason why TRTC has failed to deliver strong returns for investors, despite a strong business case, is because of its myopic financing strategy. The company is heavily reliant on convertible notes.

Why are convertible notes a red flag?

A convertible note is a financial instrument through which a lender gives money to a company with the option to convert the debt into shares of common stock at any time. Usually, these agreements are popular with small caps that face challenges accessing financing, either because they are in early development stages or because they operate in legally ambiguous industries like cannabis.

The catch with a convertible note is that the share conversion rate is always less than the prevailing market price—sometimes even at discounts as high as 70% of the prevailing share price. That way, when the lender converts their debt into shares and sells the shares, they always profit, regardless of the market price. A holder of a convertible debt is therefore always inclined to convert their debt into shares and sell them to the public at a profit, a process that mints them money but leads to the creation of more shares. In summary, the more convertible debt a company takes on, the higher the possibility that the number of outstanding shares will increase commensurately.

An increase in outstanding shares results in a decline in share price. This dilutes stock. If a hypothetical company’s share price is $10 and it has 1000 outstanding shares, it is worth $10,000 ($10 multiplied by 1000). If the worth of the company remains unchanged at $10,000, creating an additional 1000 shares (to bring total outstanding shares to 2000) will automatically cause the share price to decline to $5 (as $5 multiplied by 2000 is $10,000). This hypothetical example illustrates the dilutive impact of creating new shares on a company’s share price.

Moreover, if a company makes convertible notes its sole financing strategy, it inevitably goes into a death spiral—it becomes hooked to convertible notes and its share price remains perpetually suppressed due to continual stock dilution and selling pressure. TRTC’s heavy reliance on convertible notes is therefore a cause for alarm.

To get an inside look at TRTC’s reckless dalliance with convertible notes, go no further than its quarterly reports. Its 10-Q for the quarter ended June 30, 2017, notes that “during the six months ended June 30, 2017, senior secured convertible promissory notes and accrued interest in the amount of $8,839,084 were converted into 50,710,473 shares of common stock.”

How bad is the impact of TRTC’s convertible note addiction on common shareholders? The table below, which illustrates the rate at which outstanding shares have increased over the past five years, answers this question.

Year TRTC shares outstanding
2012 76.89 million
2013 99.04 million
2014 174.3 million
2015 240.19 million
2016 389.36 million
As of December 11th 2017 903.17 million
Shares outstanding nearing authorized shares of 990 million

In five years, TRTC’s shares outstanding have increased more than tenfold and are now inching dangerously close to its authorized shares of 990 million. This means that going forward there is very limited room for TRTC’s debt holders to convert their debt into new shares. This heightens the prospect that TRTC may default on its debt. In case this happens, shareholders will be first to lose as debt owners will foreclose on the assets. This is the benefit of being a debt holder as opposed to being a shareholder. Debt holders usually have the first claim on a company’s assets in the event of foreclosure.

To avert foreclosure and stay in business, the only foreseeable play for TRTC will be to effect a reverse split. A reverse split is where a company merges existing shares using a ratio—for example 1 share for every 20—in order to reduce the outstanding shares. This action increase the share price, but reduces the shares outstanding, meaning that it has no effect on the company’s overall value. Fewer outstanding shares also gives a company—in this case TRTC—room to create new shares in future, opening the way for more convertible notes and continued dilution of common shareholders.

Poor management

When looking at a development-stage company, especially one in an emergent industry like cannabis, an important determinant of future success is management. This is one of the points that supported our bull case for Medical Marijuana Inc. (OTCMKTS: MJNA). The CEO, Dr. Stuart Titus, has relevant experience in healthcare and understands the sector’s regulatory and stakeholder landscape well. He also has demonstrable integrity and is an esteemed member of several prestigious health associations.

The same cannot be said Derek Peterson, the CEO of TRTC. He has skills and experience, but ethics does not appear to be his strong point. A former banker handling a $100 million fund at Morgan Stanley, according to a feature on The Telegraph, it is difficult to understand why Peterson does not see the correlation between convertible notes and eroded shareholder value.

Under Peterson, TRTC has become a bona fide convertible bond junkie—the cannabis player has the ‘munchies’ for convertible debt, pun intended. TRTC may, of course, rationalize this appetite for convertible debt by pointing to the retail expansion and revenue growth. However, a company that readily turns to stock dilution in order to fund its operations cares little for its common shareholders and even less for its business. It makes you wonder what the objective of the company is, if not to enrich a few people.

To add insult to injury—as far as common shareholders are concerned—TRTC also routinely awards its CEO and CFO in shares, a move that further dilutes shareholder value.

As noted in a bullish analysis of TRTC by a writer on Seeking Alpha in July 2017: “On June 20, CFO Michael James was gifted 185,724 shares @ .17 ($31,573) by the company. Derek Peterson, CEO, was “granted” or “awarded” 324,993 shares @ .2313 ($70,171) on June 30. On the same day, Terra Tech’s CFO was also “granted” or “awarded” 244,133 shares.” Notice that these shares are awarded at a discount to the market price, presenting the executives with an incentive to liquidate.

The Seeking Alpha writer naively expressed their hope that the two senior executives would hold on to their shares instead of liquidating them. The writer would be dismayed to know that CEO Peterson swiftly offloaded more than 4 million shares between September 2017 and January 11th, 2018.

Cash out

Whether or not Derek is cashing out after having realized that the massive stock dilution has significantly reduced the odds of a sustained rally in future is anyone’s guess. What is certain is that TRTC is a strong sell. The massive stock dilution that has taken place over the past five years greatly limits the chance that this stock will deliver any solid long-term growth for investors.

All information contained herein as well as on the EmergingGrowth.com website is obtained from sources believed to be reliable but not guaranteed to be accurate or all-inclusive. All material is for informational purposes only, is only the opinion of EmergingGrowth.com and should not be construed as an offer or solicitation to buy or sell securities. The information may include certain forward-looking statements, which may be affected by unforeseen circumstances and / or certain risks. This report is not without bias. EmergingGrowth.com has motivation by means of either self-marketing or EmergingGrowth.com has been compensated by or for a company or companies discussed in this article. Full details about which can be found in our full disclosure, which can be found here, http://emerginggrowth.com/disclosure/. Please consult an investment professional before investing in anything viewed within. When EmergingGrowth.com is long shares it will sell those shares. In addition, please make sure you read and understand the Terms of Use, Privacy Policy and the Disclosure posted on the EmergingGrowth.com website.

Emerging Growth Staff
EmergingGrowth.com
305-323-5687
email us here


Source: EIN Presswire

The SafeCare Group releases its 2018 100 SafeCare Hospitals Ratings

5th consecutive listing of 100 hospitals with low infections, readmissions, complications

Our top 50 hospitals represent the top 1%, and just two percent of US hospitals earn the prestigious 100 SafeCare Hospitals distinction”

— Yisrael Safeek, MD, MBA Chairman & CEO

LEXINGTON, KY, 40509, January 12, 2018 /EINPresswire.com/ — For the fifth year in a row, The SafeCare Group® has published its 100 SafeCare Hospitals® listing of 100 hospitals with low infections, readmissions, and complications at: https://www.100safecarehospitals.com/

While all US hospitals achieving improvements deserve recognition, those achieving 100 SafeCare Hospitals distinction are leading the way. 100 SafeCare Hospitals have achieved an exemplary level of performance in the comprehensive, evidence-based metrics of the Centers of Medicare and Medicaid (CMS) value based program (HVBP), readmissions reduction program (HRRP), and acquired complications reduction program (HACRP). Hospitals that perform poorly on these quality, safety, and efficiency metrics receive a financial penalty from the government.

“Our top 50 hospitals represent the top 1%, and just two percent of US hospitals earn the prestigious 100 SafeCare Hospitals distinction," said Yisrael M. Safeek, MD, MBA, Chairman and CEO. “Since the beginning in 2013, the Mayo Clinic has made every 100 SafeCare Hospitals listing. For 2018, the Mayo Clinic is ranked number one on the 100 SafeCare Hospitals listing.”

The SafeCare Group believes that the 100 SafeCare Hospitals listings would incentivize hospital leadership to improve care and reduce unnecessary errors that harm patients.

“While healthcare outcomes have shown improvement over the last five years,” Dr. Safeek stated, “there are some glaring outliers. The data indicates that infections and readmissions remain significant challenges for hospitals. Healthcare acquired infections continue to be a blight on the nation’s healthcare system.”
Dr. Safeek added, “There’s also the revolving hospital doors for open heart and open joint procedures, as well as for chronic obstructive pulmonary disease. When you have your car’s transmission replaced, you don’t expect to return back to the mechanic again within days to fix it. Why then should patients who had medical or surgical treatments expect less?”

Visitors are encouraged to explore the newly redesigned website offering quick and easy access to essential information and features that offers a more comprehensive understanding of 100 SafeCare Hospitals®.

About The SafeCare Group
The SafeCare Group was founded in 2010 and is a privately held company with the motto Softwaring Healthcare Excellence®. The SafeCare Group software solutions enable hospitals to take advantage of disruptive healthcare technologies that optimize hospital reimbursement and accreditation. Since 2012, SafeCare Analytics® have been helping hospitals excel with physician privileging software for Joint Commission OPPE, and hospital software for better readmissions, cost, complications and infections. Since 2013, 100 SafeCare Hospitals® listings have been Recognizing Healthcare Excellence® of 100 US hospitals that excelled with low infections, readmissions, and complications. Since 2015, SafeCare® magazine has been delivering information on the people, ideas and novel technologies affecting access, cost, and quality of healthcare across the globe. For more information about The SafeCare Group, visit www.safecaregroup.com.

Sarju Bharucha, JD
SafeCare Magazine
800-700-9481
email us here

Comparative Performance of 100 SafeCare Hospitals®


Source: EIN Presswire

Jim Miller, Chairman and CEO of ImageWare Systems Joins Us “In The Boardroom” on SecuritySolutionsWatch.com

Jim Miller, Chairman and CEO, ImageWare Systems

www.IWSINC.com

www.SecuritySolutionsWatch.com

ImageWare Provides Major Enhancements to GoVerifyID Product Line – GoVerifyID Adds New Authentication Methods, Including FUJITSU Matching Algorithm Palm Images

ImageWare® Systems, Inc. (OTCQB:IWSY)

We are honored to have Jim Miller join us "In The Boardroom" at this time to discuss the many exciting recent developments at ImageWare with partners such as Fujitsu, IBM and SAP, just to name a few.”

— Martin Eli, Publisher

NEW YORK, NY, USA, January 12, 2018 /EINPresswire.com/ — Jim Miller, Chairman and CEO of ImageWare Systems joined us “In The Boardroom” to discuss recent developments.
The entire interview is here: http://securitysolutionswatch.com/Interviews/in_Boardroom_ImageWare.html

On December 22, 2017, ImageWare released the following:
<<ImageWare® Systems, Inc. (ImageWare or IWS) (OTCQB: IWSY), a leader in mobile and cloud-based, multi-modal biometric identity management solutions, announces the availability of major enhancements to its GoVerifyID® mobile app, GoMobile Interactive® (GMI) cloud platform, and GoVerifyID Enterprise Suite products. These product updates build upon ImageWare’s patented, ultra-scalable, and adaptable biometric authentication systems to provide even broader end-to-end solutions.

ImageWare has extended the authentication methods that are available in the GoVerifyID mobile app and GoMobile Interactive cloud service to give users and organizations even more choices, while further increasing convenience, identity assurance, and security. GoVerifyID now provides palm image recognition using the latest FUJITSU Matching Algorithm as an authentication option along with face, voice, and fingerprint recognition. Additionally, ImageWare now offers an optional 6-digit secret PIN as an alternate, non-biometric authentication method.

ImageWare has extended the GoVerifyID integration with enterprise ecosystems for both Microsoft® and IBM® environments. ImageWare introduced a new Credential Provider for GoVerifyID Enterprise Suite for Windows. This provides additional security features for Windows computers, including support for Windows® Biometric Framework compatible devices. GoVerifyID for IBM Security Access Manager (ISAM) was also recently released to provide turnkey integration similar to the end-to-end GoVerifyID solutions for CA®, SAP®, and Aruba® systems.

“As part of our continued commitment to help organizations secure their business and simplify user experience, we have released our newest versions of the GoVerifyID® family of products” said Jim Miller, Chairman and CEO of ImageWare. “By increasing the number of options for biometric and non-biometric authentication methods, ImageWare gives users and organizations the ultimate in choice, flexibility, user assurance, and security.”

“Using our new FUJITSU Matching Algorithm for palm image recognition on your mobile phone along with a secret PIN provides the preeminent ‘what you have,’ ‘what you know,’ and ‘what you are’ multi-factor authentication solution. We provide this GoVerifyID technology as part of FUJITSU Biometrics-as-a-Service™” said Jason Bradlee, Head of Security for Americas region, Fujitsu America, Inc. “Our studies have shown that often people prefer to submit an image of their palm rather than taking a selfie, as it is less obtrusive and more private.”

More detailed information is available in the GoVerifyID Product Update document:
http://info.iwsinc.com/GoVerifyID-Product-Release-Dec-2017>&gt;

Trademarks:
Fujitsu, the Fujitsu logo, PalmSecure, K5, Finplex and “shaping tomorrow with you” are trademarks or registered trademarks of Fujitsu Limited in the United States and other countries. Biometrics-as-a-Service is a trademark or registered trademark of Fujitsu America, Inc. in the United States and other countries. ImageWare, GoVerifyID and GoMobile Interactive are trademarks or registered trademarks of ImageWare Systems, Inc.in the United States and other countries. Microsoft and Windows are trademarks or registered trademarks of Microsoft Corporation in the United States and other countries. IBM is a trademark or registered trademark of IBM Corporation in the United States and other countries. CA is a trademark or registered trademark of CA Technologies in the United States and other countries. SAP is a trademark or registered trademark of SAP SE in the United States and other countries. Aruba is a trademark or registered trademark of Hewlett Packard Enterprise Development LP in the United States and other countries. All other trademarks referenced herein are the property of their respective owners.

In other recent industry news, Fujitsu America announced on January 9, 2018 that,
“Fujitsu Extends the Global Reach for Biometrics-as-a-Service Offerings
News facts:
• Expands Fujitsu Biometrics-as-a-Service offering to include Canada, Mexico and the Caribbean along with the rest of the Americas
• Fujitsu customers in the expanded area of availability can now deploy multi-factor, multi-modal Biometrics-as-a-Service quickly and easily upgrade their security processes”

For the complete Fujitsu America Press Release:
http://www.fujitsu.com/us/about/resources/news/press-releases/2018/fai-20180109.html

***************************************************************************************************************
About SecuritySolutionsWatch.com
———————————————–
www.SecuritySolutionsWatch.com features thought leadership, content marketing, interviews about IT, IoT and security solutions. Our flagship “In The Boardroom” program, now in its 15th year, has delivered outstanding content about solutions from leading global brands such as: 3M, ASSA ABLOY, Cisco Security, Dell EMC, HP Cybersecurity, Fujitsu, Gemalto, HID Global, IBM, ImageWare, Intel, SAP, Siemens Security, Stanley Security, SONY Security, Yahoo, and Unisys just to name a few.

What's YOUR cybersecurity, physical security, mobility, payments, safety "smart" or blockchain solution?

We invite you to please join us "In The Boardroom" at www.SecuritySolutionsWatch.com.
For a quick tour to see exactly how your brand will be featured, please contact Ali Eng on our publishing team via email: ALE@SecuritySolutionsWatch.com, or phone: 1+914.690.9351 .

More details here: http://www.securitysolutionswatch.com/Main/ThoughtLeadershipOpportunity_July2017.pdf
Media Kit here: http://www.securitysolutionswatch.com/MediaKit.html

For SecuritySolutionsWatch.com content-marketing and lead generation offerings and services, please see our Rate Card here: http://www.securitysolutionswatch.com/Main/170502%20RATE_CARD-4.pdf
****************************************************************************************************************
It's FREE…our monthly newsletter with thought leadership content from leading security experts.
Please click here: www.securitysolutionswatch.com/newsletters/newsletter_2017_12.html
And please visit us on Twitter here: https://twitter.com/SecStockWatch
****************************************************************************************************************
THIS PRESS RELEASE, AND ALL ADVERTISING, CONTENT AND ALL OTHER MATERIAL AND INFORMATION WHICH APPEARS ON SECURITYSOLUTIONSWATCH.COM AND/OR SECURITYSTOCKWATCH.COM, ONLINE AND/OR IN PRINT, IS SUBJECT TO OUR TERMS OF USE, CONDITIONS, AND DISCLAIMER HERE: www.SecuritySolutionsWatch.com/Main/Terms_of_Use.html.

Martin Eli, Publisher
SecuritySolutionsWatch.com
1+914.690.9351
email us here

2017 Mobile World Congress Presentation


Source: EIN Presswire

Global Electrochemical Biosensors Market 2018 Share, Trend, Segmentation And Forecast To 2023

Electrochemical Biosensors -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2023

PUNE, MAHARASHTRA, INDIA, January 12, 2018 /EINPresswire.com/ — Electrochemical Biosensors Industry

Description

Wiseguyreports.Com Adds “Electrochemical Biosensors -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2023” To Its Research Database

Electrochemical biosensors are analytical devices used to provide analytical information by biological sample, such as tissues, enzymes and whole cell, to an electrical signal. It is cost effective, user friendly, simple, disposable and convenient. Potentiometric sensors, amperometric sensors and conductometric sensor are detection modes of electrochemical detection. It is used mostly in miniaturized devices and is used for the detection of biological and non-biological matrices.

The global electrochemical biosensors market is expected to reach USD 23,707.2 million by 2022 at a CAGR of 9.7% during the forecast period. 
The global electrochemical biosensors by applications is segmented into diagnosis, patient monitoring and others. Diagnosis segment accounted for the largest market by application. The major factor that influence the growth of the market are the need for analyses in the clinical area with reliable analytical methods and devices. Diagnosis segment accounted for the largest market share of around 54.1% in 2016, and is anticipated to grow at a CAGR of 9.5% during the forecasted period 2016-2022. 

Request for Sample Report @ https://www.wiseguyreports.com/sample-request/2375992-global-electrochemical-biosensors-market-trends-forecast-2017-to-2022

The global electrochemical biosensors by end user is majorly segmented into point of care testing, diagnostics center, research laboratories and others. The point of care segment holds the largest market by end user in 2016. Point of care testing segment accounted for the largest market share of around 45.2% in 2016, with a market value of USD 5,521.9 million and is anticipated to grow at a CAGR of 9.9% during the forecasted period 2017-2022. 

On the basis of regions, the market is segmented into North America, Europe, Asia-Pacific and the Middle East & Africa. North America accounted for the largest market share of 43.0% in 2016, with a market value of USD 5,251.5 million and is projected to grow at a CAGR of 9.4% during the forecast period. Europe was the second-largest market in 2016, valued at USD 3,690.5 million in 2016; it is projected to grow at a CAGR of 9.8%. However, Asia Pacific is projected to grow at the highest CAGR of 10.0%.

Key Players 

The leading market players in the global electrochemical biosensors market include: F. Hoffmann-La Roche AG, Medtronics, Bayer AG, Abbott Laboratories, I-SENS, Inc, Siemens Healthcare GmbH and others. 

Study objectives 
• Providing a detail analysis of the electrochemical biosensors market structure along with forecast for the next 7 years related to various segments and sub-segments of the market. 
• Giving insights about factors affecting the market growth. 
• Analyzing the market based on various analysis which includes price analysis, supply chain analysis, Porters Five Force analysis etc. 
• Giving the past revenue and estimated future revenue of the market’s segments and sub-segments with respect to the main market and small scale market of the same present globally. 
• Giving regional level analysis of the market with respect to the current market size and future growth prospect of the same. 
• Giving regional level analysis of the market with respect to segments which includes by application and by end user also giving regional level analysis of the market’s sub-segments. 
• Providing an overview of key players and their strategic profiling in the market; comprehensively analyzing their core competencies and drawing the market’s competitive structure. 
• Tracking and analyzing competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments along with research and developments taking place in the global Electrochemical biosensors market 

Leave a Query @ https://www.wiseguyreports.com/enquiry/2375992-global-electrochemical-biosensors-market-trends-forecast-2017-to-2022

Target Audience 
• Electrochemical biosensors manufacturers 
• Pharmaceutical companies 
• Biotechnology companies 
• Academic research institutes 
• Government institutes 

Key Findings 
• Diagnosis segment accounted for the largest market share of around 54.1% in 2016, with a market value of USD 6,600 million and is anticipated to grow at a CAGR of 9.5% during the forecasted period 2016-2022. 
• Point of care testing segment accounted for the largest market share of around 45.2% in 2016, with a market value of USD 5,521.9 million and is anticipated to grow at a CAGR of 9.9% during the forecasted period 2017-2022 
• North America accounted for the largest market share of 43.0% in 2016, with a market value of USD 5,251.5 million and is projected to grow at a CAGR of 9.4% during the forecast period 

The reports also covers regional analysis 
• North America 
o US 
o Canada 
• Europe 
o Germany 
o France 
o U.K. 
o Italy 
o Spain 
o Rest of Europe 
• Asia Pacific 
o Japan 
o China 
o India 
o Republic of Korea 
o Rest of Asia-Pacific 
• Middle East & Africa 
o Middle East 
o Africa

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=2375992

Continued…           

Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (Us)  Ph: +44 208 133 9349 (Uk)

NORAH TRENT
Wise Guy Reports
+91 841 198 5042
email us here


Source: EIN Presswire